女性 发表于 2025-3-21 16:15:30
书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0270736<br><br> <br><br>书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0270736<br><br> <br><br>袋鼠 发表于 2025-3-21 23:16:05
0927-3042 Overview: 978-1-4757-8267-7978-0-585-38571-6Series ISSN 0927-3042 Series E-ISSN 2509-8497Pelvic-Floor 发表于 2025-3-22 02:28:42
http://reply.papertrans.cn/28/2708/270736/270736_3.pngSolace 发表于 2025-3-22 07:12:41
http://reply.papertrans.cn/28/2708/270736/270736_4.png竖琴 发表于 2025-3-22 12:30:19
Ziming Zheng,Andrew A. Chien,Keita Teranishiproliferative disease arising in immunocompromised populations, in Hodgkin’s disease, and in peripheral T-cell lymphoma. The association is of interest in terms of the pathogenesis of these tumors and is becoming important in terms of new approaches to treatment. The purpose of this chapter is to rejagged 发表于 2025-3-22 13:06:40
https://doi.org/10.1007/978-3-319-17353-5n of either B or T lymphocytes but differing in clinical presentation, prognosis, and treatment strategies. In 1997, the estimated number of new cases of NHL was 53,600, with a slight preponderance toward males (M/F ratio: 1.3).. The estimated number of deaths secondary to NHL was 23,800 (44.4%) injagged 发表于 2025-3-22 19:29:56
http://reply.papertrans.cn/28/2708/270736/270736_7.png试验 发表于 2025-3-23 00:04:09
Ziming Zheng,Andrew A. Chien,Keita Teranishidistinct clinical and pathologic subtype that accounts for approximately 10% of acute myeloid leukemia (AML) cases. The unique features of APL have been well described [.–.] and include a characteristic morphologic appearance ., a reciprocal translocation between the long arms of chromosomes 15 andmaverick 发表于 2025-3-23 01:34:41
http://reply.papertrans.cn/28/2708/270736/270736_9.png甜瓜 发表于 2025-3-23 07:59:26
Rui Pinheiro,Nuno Roma,Pedro Tomásproliferation of clonal plasma cells that are resistant to standard doses of commonly employed agents at the time of diagnosis, resulting in complete remission (CR) rates of only 5%–10% and median survival of approximately three years. This inherent resistance is probably due to an array of molecula